Isfahan University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
Evaluation of the Effects A2b Adenosine Receptor-Agonist (Bay 60–6583) in Induction of Apoptosis in Achn Renal Cancer Cell Line Publisher



Shafiee AV1 ; Sharifi M1
Authors
Show Affiliations
Authors Affiliations
  1. 1. Department of Genetics and Molecular Biology, School of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran

Source: Journal of Isfahan Medical School Published:2018


Abstract

Background: A2B adenosine receptor (A2BAR) is member of the family of seven transmembrane G protein coupled receptor that are activated in high concentration of extracellular adenosine that occur in certain pathophysiological conditions. Activation of the A2B adenosine receptor in tumor cell line limits or promotes tumor growth. In current study, we investigated the role of A2B adenosine receptor-agonist in apoptosis induction in ACHN renal cancer cell line. Methods: ACHN renal cancer cell line was selected to investigate the effect of A2B adenosine receptor-agonist (BAY 60-6583) on apoptosis. The cells were cultured in high glucose Dulbecco's Modified Eagle's Medium (DMEM) (10% FBS and 1% penicillin/streptomycin). Cell viability and apoptosis were evaluated using 3-(4,5-Dimethylthiazol-2-yl)-2,5-Diphenyltetrazolium bromide (MTT) assay and Annexin V/propidium iodide (PI), respectively. Findings: Based on MTT assay, treated samples with 50, 100 and 200 μmol of BAY 60-6583 had approximately 50% viability after 48 hours. In addition, based on Annexin V/propidium iodide test, 50 and 100 μmol concentration of BAY 60-658 induced the most apoptosis after 48 hours. Conclusion: According to the results, it can be concluded that BAY 60-6583 induces apoptosis in ACHN cell line with A2B adenosine receptor stimulation, therefore the A2B adenosine receptor-agonists can be used as agent that inhibit cancer growth. © 2018, Isfahan University of Medical Sciences(IUMS). All rights reserved.
Related Docs
View other Related Docs
1. Activation of A2b Adenosine Receptor Regulates Ovarian Cancer Cell Growth: Involvement of Bax/Bcl-2 and Caspase-3, Biochemistry and Cell Biology (2015)
2. The Effect of Adenosine A1 Receptor Agonist and Antagonist on P53 and Caspase 3, 8, and 9 Expression and Apoptosis Rate in Mcf-7 Breast Cancer Cell Line, Research in Pharmaceutical Sciences (2016)
3. Adenosine A1 Receptor Modifies P53 Expression and Apoptosis in Breast Cancer Cell Line Mcf-7, Bratislava Medical Journal (2016)
4. Adenosine Induces Cell-Cycle Arrest and Apoptosis in Androgen-Dependent And-Independent Prostate Cancer Cell Lines, Lncap-Fgc-10, Du-145, and Pc3, Prostate (2012)
5. Molecular Mechanisms of A3 Adenosine Receptor-Induced G1 Cell Cycle Arrest and Apoptosis in Androgen-Dependent and Independent Prostate Cancer Cell Lines: Involvement of Intrinsic Pathway, Journal of Cancer Research and Clinical Oncology (2011)
6. Mitochondrial and Caspase Pathways Are Involved in the Induction of Apoptosis by Ib-Meca in Ovarian Cancer Cell Lines, Tumor Biology (2014)
7. Adenosine Induces Cell Cycle Arrest and Apoptosis Via Cyclind1/Cdk4 and Bcl-2/Bax Pathways in Human Ovarian Cancer Cell Line Ovcar-3, Tumor Biology (2013)
8. Molecular Expression of Adenosine Receptors in Ovcar-3, Caov-4 and Skov-3 Human Ovarian Cancer Cell Lines, Research in Pharmaceutical Sciences (2015)
Experts (# of related papers)
View all Related Experts
Mojtaba Panjehpour (15)
Mahmoud Aghaei (13)
Other Related Docs
9. Expression of Adenosine Receptor Subclasses in Malignant and Adjacent Normal Human Prostate Tissues, Prostate (2015)
10. Physiological Role of Adenosine and Its Receptors in Tissue Hypoxia-Induced Angiogenesis, Physiology and Pharmacology (2012)
11. Estrogen Stimulates Adenosine Receptor Expression Subtypes in Human Breast Cancer Mcf-7 Cell Line, Research in Pharmaceutical Sciences (2018)
12. Adenosine Modulates Cell Growth in the Human Breast Cancer Cells Via Adenosine Receptors, Oncology Research (2007)
13. Expression of A2a and A2b Adenosine Receptors in Human Breast Tumors, Journal of Isfahan Medical School (2011)
14. Investigation the Effect of Adenosine A1 Receptor Agonist and Antagonist on P53 Gene Expression, and Apoptosis Pathways and Rate in U87mg Multiform Glioblastoma, Journal of Isfahan Medical School (2021)
15. Expression of A1 and A3 Adenosine Receptors in Human Breast Tumors, Tumori (2012)
16. A2b Adenosine Receptor Agonist Induces Cell Cycle Arrest and Apoptosis in Breast Cancer Stem Cells Via Erk1/2 Phosphorylation, Cellular Oncology (2018)
17. A3 Adenosine Receptor Agonist Induce G1 Cell Cycle Arrest Via Cyclin D and Cyclin-Dependent Kinase 4 Pathways in Ovcar-3 and Caov-4 Cell Lines, Journal of Cancer Research and Therapeutics (2017)
18. Apoptosis and Cell Cycle Regulatory Effects of Adenosine by Modulation of Gli-1 and Erk1/2 Pathways in Cd44+ and Cd24− Breast Cancer Stem Cells, Cell Proliferation (2017)
19. A2a Adenosine Receptor Agonist Improves Endoplasmic Reticulum Stress in Min6 Cell Line Through Protein Kinase A/ Protein Kinase B/ Cyclic Adenosine Monophosphate Response Element-Binding Protein/ and Growth Arrest and Dna-Damage-Inducible 34/ Eukaryotic Initiation Factor 2Α Pathways, Journal of Cellular Physiology (2019)
20. A3 Receptor Agonist, Cl-Ibmeca, Potentiate Glucose-Induced Insulin Secretion From Min6 Insulinoma Cells Possibly Through Transient Ca2+ Entry, Research in Pharmaceutical Sciences (2019)
21. Adenosine Receptor Expression in Two Different Human Cancer Cell Lines at Molecular Level, Iranian Journal of Cancer Prevention (2010)